Carret Asset Management, LLC Pfizer Inc Transaction History

Carret Asset Management, LLC

$891 Million
Q4 2024

A detailed history of Carret Asset Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Carret Asset Management, LLC holds 113,704 shares of PFE stock, worth $3.04 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

113,704

Previous 115,772 1.79%

Holding current value

$3.04 Million

Previous $3.35 Million 9.97%

% of portfolio

0.34%

Previous 0.37%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$24.8 - $30.19 $51,286 - $62,432	-2,068 Reduced 1.79%	113,704 $3.02 Million
Q3 2024 Oct 24, 2024	SELL	$27.7 - $31.39 $103,875 - $117,712	-3,750 Reduced 3.14%	115,772 $3.35 Million
Q2 2024 Aug 01, 2024	SELL	$25.26 - $29.6 $85,757 - $100,492	-3,395 Reduced 2.76%	119,522 $3.34 Million
Q1 2024 Apr 18, 2024	BUY	$25.89 - $29.73 $299,728 - $344,184	11,577 Added 10.4%	122,917 $3.41 Million
Q4 2023 Feb 02, 2024	SELL	$26.13 - $33.94 $84,504 - $109,761	-3,234 Reduced 2.82%	111,340 $3.21 Million
Q3 2023 Oct 12, 2023	SELL	$32.09 - $37.51 $48,873 - $57,127	-1,523 Reduced 1.31%	114,574 $3.8 Million
Q2 2023 Jul 25, 2023	BUY	$36.12 - $41.79 $36,950 - $42,751	1,023 Added 0.89%	116,097 $4.26 Million
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $326,543 - $425,111	-8,290 Reduced 6.72%	115,074 $4.7 Million
Q4 2022 Jan 10, 2023	BUY	$41.75 - $54.5 $20,916 - $27,304	501 Added 0.41%	123,364 $6.32 Million
Q3 2022 Oct 11, 2022	SELL	$43.76 - $53.42 $7,701 - $9,401	-176 Reduced 0.14%	122,863 $5.38 Million
Q2 2022 Aug 04, 2022	SELL	$46.53 - $55.17 $12,656 - $15,006	-272 Reduced 0.22%	123,039 $6.45 Million
Q1 2022 Apr 13, 2022	BUY	$45.75 - $56.69 $213,972 - $265,139	4,677 Added 3.94%	123,311 $6.38 Million
Q4 2021 Jan 10, 2022	BUY	$41.32 - $61.25 $66,153 - $98,061	1,601 Added 1.37%	118,634 $7.01 Million
Q3 2021 Oct 27, 2021	SELL	$39.25 - $50.42 $157,431 - $202,234	-4,011 Reduced 3.31%	117,033 $5.03 Million
Q2 2021 Jul 14, 2021	SELL	$35.91 - $40.68 $112,218 - $127,125	-3,125 Reduced 2.52%	121,044 $4.74 Million
Q1 2021 Jul 14, 2021	SELL	$33.49 - $37.77 $20,294 - $22,888	-606 Reduced 0.49%	124,169 $4.5 Million
Q4 2020 Mar 16, 2021	BUY	$33.47 - $42.56 $23,462 - $29,834	701 Added 0.56%	124,775 $4.59 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $67,310 - $78,970	2,120 Added 1.74%	124,074 $4.55 Million
Q2 2020 Aug 12, 2020	BUY	$30.12 - $36.54 $73,824 - $89,559	2,451 Added 2.05%	121,954 $3.99 Million
Q1 2020 May 18, 2020	SELL	$27.03 - $38.62 $100,821 - $144,052	-3,730 Reduced 3.03%	119,503 $3.9 Million
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $51,256 - $58,169	1,557 Added 1.28%	123,233 $4.83 Million
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $31,190 - $40,444	-960 Reduced 0.78%	121,676 $4.37 Million
Q2 2019 Aug 12, 2019	BUY	$36.98 - $41.52 $1,035 - $1,162	28 Added 0.02%	122,636 $5.31 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $72,075 - $79,186	-1,922 Reduced 1.54%	122,608 $5.21 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $10,309 - $11,754	-268 Reduced 0.21%	124,530 $5.44 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $12,064 - $14,633	350 Added 0.28%	124,798 $5.5 Million
Q2 2018 Aug 08, 2018	SELL	$32.98 - $35.16 $22,558 - $24,049	-684 Reduced 0.55%	124,448 $4.52 Million
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $18,348 - $21,286	575 Added 0.46%	125,132 $4.44 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $26,308 - $27,914	-791 Reduced 0.63%	124,557 $4.51 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $181,288 - $199,709	5,848 Added 4.89%	125,348 $4.48 Million
Q2 2017 Aug 15, 2017	BUY	N/A	119,500	119,500 $4.01 Million

Others Institutions Holding PFE

# of Institutions

3,357

Shares Held

3.69B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carret Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carret Asset Management, LLC with notifications on news.

Account

Carret Asset Management, LLC Pfizer Inc Transaction History